Table 2.
Antibiotic |
1st regimen (n = 287) |
2nd regimen (n = 163) |
3rd regimen (n = 37) |
---|---|---|---|
Cephazolin | 131 (46%) | 24 (15%) | 3 (8%) |
Vancomycin | 129 (45%) | 77 (47%) | 17 (46%) |
Gentamicin | 203 (71%) | 20 (12%) | 7 (19%) |
Other Aminoglycoside | 1 (0.3%) | 1 (1%) | 0 (0%) |
Ceftazidime | 21 (7%) | 3 (2%) | 0 (0%) |
Cefoxitin | 9 (3%) | 1 (1%) | 0 (0%) |
Cefipime | 1 (0.3%) | 1 (1%) | 0 (0%) |
Cephalothin | 13 (5%) | 5 (3%) | 0 (0%) |
Ceftriaxone | 10 (3%) | 4 (2%) | 0 (0%) |
Cefotaxime | 0 (0%) | 2 (1%) | 0 (0%) |
Cephalexin | 13 (5%) | 14 (9%) | 4 (11%) |
Other cephalosporin | 4 (1%) | 0 (0%) | 0 (0%) |
Ampicillin | 3 (1%) | 5 (3%) | 2 (5%) |
Amoxycillin | 1 (0.3%) | 9 (6%) | 3 (8%) |
Amoxycillin+clavulanate | 6 (2%) | 8 (5%) | 3 (8%) |
Dicloxacillin/Flucloxacillin | 4 (1%) | 3 (2%) | 1 (3%) |
Other penicillin | 2 (1%) | 2 (1%) | 0 (0%) |
Ciprofloxacin | 17 (6%) | 3 (2%) | 4 (11%) |
Metronidazole | 2 (1%) | 4 (3%) | 1 (2%) |
Cotrimoxazole | 1 (0.3%) | 0 (0%) | 0 (0%) |
Erythromycin | 0 (0%) | 1 (1%) | 3 (1%) |
Antifungal agent | 2 (1%) | 5 (3%) | 3 (8%) |
Other | 3 (1%) | 6 (4%) | 0 (0%) |
Results represent number of episodes treated with antibiotic (% of total treated with 1st, 2nd or 3rd line regimen). Note that values within each column add to more than 100% because of the use of combination antimicrobial regimens.